ALIVE.

MOC Awareness / Facts

Understanding

Mucinous Ovarian Cancer

A rare and distinct ovarian cancer that often affects younger people and needs specialized diagnosis, treatment, and research.

2.4-3% of epithelial ovarian cancers
~200 UK diagnoses each year
45 average age at diagnosis
80% diagnosed at stage 1
01

What is MOC?

Mucinous ovarian cancer is a rare epithelial tumor filled with mucus. It behaves differently from more common ovarian cancers and represents roughly 2.4% to 3% of epithelial cases.

02

Who is affected?

MOC tends to affect younger people. The average age at diagnosis is 45, and it is frequently found in people under 40.

03

Signs to notice

Tumors can become extremely large and may feel like a lump on one side of the abdomen. Symptoms include bloating, pelvic pain, weight gain, and feeling full quickly.

04

Markers, risk & genetics

CA-125 may be normal or only mildly elevated, while CEA or CA19-9 may be raised. MOC is not linked to the usual family-history risk pattern. Smoking is the only currently identified risk factor; KRAS and TP53 mutations are common.

05

Why diagnosis is difficult

About 80% of mucinous tumors found in the ovary are metastatic, often originating in the gastrointestinal tract, pancreas, or appendix. Rigorous pathology and tissue staining are needed to distinguish them from primary MOC.

06

Treatment pathways

Large tumors often cause earlier symptoms, so most cases are found at stage 1. Surgery is the primary treatment and can sometimes preserve fertility. Advanced MOC is difficult to treat because it is less sensitive to standard platinum chemotherapy.

Research matters

Its rarity and treatment resistance make dedicated research urgent. There have been no successful clinical trials exclusively for MOC, leaving major gaps in evidence for advanced disease.

Support can be practical

Help with appointments, meals, transport, or everyday needs. Support rare ovarian cancer advocacy groups and research focused on better treatments.